These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 4996980)

  • 1. [Serologic studies of patients under treatment with xenogenous antilymphocyte globulin].
    Hopf U; Fateh-Moghadam A; Land W; Brendel W
    Klin Wochenschr; 1970 Aug; 48(15):906-13. PubMed ID: 4996980
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic reactions to a horse globulin therapy and their prevention by induction of immunological tolerance.
    Ring J; Seifert J; Lob G; Hopf U; Land W; Brendel W
    Allergol Immunopathol (Madr); 1974; 2(2):93-8. PubMed ID: 4211785
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensive immunosuppression in the treatment of multiple sclerosis.
    Ring J; Seifert J; Lob G; Coulin K; Angstwurm H; Frick E; Brass B; Mertin J; Backmund H; Brendel W
    Lancet; 1974 Nov; 2(7889):1093-6. PubMed ID: 4139403
    [No Abstract]   [Full Text] [Related]  

  • 4. Reactivities to horse anti-lymphocyte globulin. I. Induction of immunologic tolerance in man.
    Gewurz H; Moberg A; Simmons R; Pollara B; Soll R; Najarian S
    Int Arch Allergy Appl Immunol; 1970; 39(2-3):113-20. PubMed ID: 4990554
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies in immuno-suppression. Methods to evaluate anti-human lymphocyte sera.
    Balner H; Dersjant H; van Bekkum DW
    Transplant Proc; 1969 Mar; 1(1):629-37. PubMed ID: 5002666
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the decline in immunosuppressive potency of rabbit anti-mouse thymocyte sera raised by repeated immunization of the same rabbit.
    Ponsford FM; Symes MO
    Folia Biol (Praha); 1971; 17(4):227-35. PubMed ID: 5002373
    [No Abstract]   [Full Text] [Related]  

  • 7. [The behavior of immunoglobulins and antibody formation during treatment with heterologous antilymphocyte serum].
    Fateh-Moghadam A; Pichlmayr R; Morell C; Knedel M
    Klin Wochenschr; 1967 Jul; 45(13):665-70. PubMed ID: 4172949
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterophil antibodies in the sera of recipients in clinical renal transplantation.
    O'Kane HO; Shorter RG; Nava C; Hallenbeck GA
    Surgery; 1969 Oct; 66(4):682-6. PubMed ID: 4898465
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders.
    Brendel W; Seifert J; Lob G
    Proc R Soc Med; 1972 Jun; 65(6):531-5. PubMed ID: 5035906
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antilymphocytic serum (antilymphocyte globulin) in the management of transplants].
    Gieldanowski J
    Wiad Lek; 1970 Nov; 23(22):1971-7. PubMed ID: 4395160
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactivities to horse anti-lymphocyte globulin. II. Serum sickness nephritis with complement alterations in man.
    Gewurz H; Pickering RJ; Moberg A; Simmons RL; Good RA; Najarian JS
    Int Arch Allergy Appl Immunol; 1970; 39(2-3):210-20. PubMed ID: 4990556
    [No Abstract]   [Full Text] [Related]  

  • 12. Preliminary studies on antithymocyte globulin.
    Orlowski T; Skopińska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z
    Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical use of ALG.
    Brendel W
    Transplant Proc; 1971 Mar; 3(1):280-6. PubMed ID: 5095885
    [No Abstract]   [Full Text] [Related]  

  • 14. ALG treatment of Rhesus monkeys. Attempts to reduce complications by the induction of tolerance.
    Balner H; Yron I; Dersjant H; Zaalberg O; Betel I
    Transplantation; 1970 Nov; 10(5):416-24. PubMed ID: 4992451
    [No Abstract]   [Full Text] [Related]  

  • 15. [Attempt for an induction of immune tolerance against horse IgG in men].
    Land W; Brendel W; Hopf U; Seifert J
    Klin Wochenschr; 1970 Feb; 48(4):241-4. PubMed ID: 5523317
    [No Abstract]   [Full Text] [Related]  

  • 16. The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin.
    James K; Pullar DM; Morton JB; Dalton RG; Nolan B; Woodruff MF
    Clin Exp Immunol; 1971 Apr; 8(4):529-42. PubMed ID: 4995934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and effect of heterologous anti-canine lymphocyte serum.
    Pichlmayr R; Brendel W; Zenker R
    Surgery; 1967 May; 61(5):774-83. PubMed ID: 5337424
    [No Abstract]   [Full Text] [Related]  

  • 18. [Induction of tolerance of heterologous protein in therapy with antilymphocytic globulin in man].
    Tilz GP
    Med Klin; 1972 Mar; 67(12):410-3. PubMed ID: 4112374
    [No Abstract]   [Full Text] [Related]  

  • 19. Production of human antilymphocytic serum in horse with thoracic duct lymphocytes and peripheral blood lymphocytes.
    Traeger J; Fries D; Revillard JP; Durix A; Carraz M; Plan M
    Fed Proc; 1970; 29(1):108-10. PubMed ID: 4904617
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of immunologic tolerance to antilymphocyte globulin in man.
    Gewurz H; Moberg AW; Simmons RL; Pollara B; Gunnarsson A; Soll R; Najarian JS
    Surg Forum; 1969; 20():259-61. PubMed ID: 4986402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.